[Sympathetic nerve in rat with pressure overload left ventricular hypertrophy]

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Pharmacology

Context:

• Pressure overload leads to left ventricular hypertrophy (LVH), a significant risk factor for heart failure.
• Sympathetic nervous system overactivity plays a crucial role in the progression of LVH.
• Understanding the mechanisms of cardiac remodeling is vital for developing effective therapeutic strategies.

Purpose:

• To investigate the myocardial and sympathetic nerve remodeling in pressure overload-induced LVH.
• To elucidate the protective effects of statins (HMG CoA inhibitors) on cardiac remodeling and sympathetic innervation.

Summary:

• Rats with abdominal aortic coarctation developed significant LVH, characterized by increased cardiac mass and altered cardiac function.
• Treatment with a statin reversed LVH and modulated sympathetic innervation markers, including nerve growth factor (NGF), growth associated protein-43 (GAP43), and tyrosine hydroxylase (TH).
• The study demonstrated that statins inhibit sympathetic innervation in abdominal aortic-clamped animals.

Impact:

• Provides insights into the therapeutic potential of statins in managing LVH and associated sympathetic dysfunction.
• Identifies key molecular targets for intervention in cardiac remodeling.
• Contributes to the understanding of cardiovascular disease pathogenesis and treatment.